Pharmaceutics Exam 3 + Cumulative Stuff

0.0(0)
Studied by 2 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/97

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 7:39 PM on 12/3/24
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

98 Terms

1
New cards

Pharmaceutics

The science of designing, developing, and formulating drugs into dosage forms that are safe, effective, and convenient for patient use.

2
New cards

Importance of Pharmaceutics

Ensures proper drug formulation for desired therapeutic effects, improves drug bioavailability, stability, and patient compliance.

3
New cards

Pharmaceutical Formulation Process

Involves designing a drug product with active pharmaceutical ingredients (APIs) and excipients to ensure stability, efficacy, and patient acceptability.

4
New cards

Difference Between Formulation and Compounding

Formulation is large-scale and standardized for commercial use, while compounding is small-scale and tailored to specific patient needs.

5
New cards

Stages of Drug Development

Include preclinical studies, IND application, clinical trials, NDA, and post-marketing surveillance.

6
New cards

FDA Approval Process

Involves application submissions at various stages to ensure drug safety and efficacy.

7
New cards

Importance of Pharmaceutics in Drug Development

Ensures drugs are formulated for optimal absorption, distribution, metabolism, and excretion (ADME).

8
New cards

United States Pharmacopeia (USP)

Sets standards for the quality, purity, strength, and consistency of medicines.

9
New cards

National Formulary (NF)

Focuses on excipients and inactive ingredients in pharmaceutical formulations.

10
New cards

Typical Drug Monograph Components

Includes official drug name, physical properties, identification tests, assay, permissible impurities, storage conditions, and dosage forms.

11
New cards
USP

Regulates sterile compounding and prevents contamination.

12
New cards
USP

Regulates non-sterile compounding and addresses stability and hygiene.

13
New cards

Reasons for Drug Dosage Forms

To improve stability, enhance bioavailability, ensure controlled release, and improve patient compliance.

14
New cards

Principles of Dosage Form Design

Safety, efficacy, stability, acceptability, and convenience of dosage forms.

15
New cards

Importance of Pre-Formulation Studies

Assess the physical, chemical, and biopharmaceutical properties of drugs for better formulation.

16
New cards

Routes of Administration Consideration

Determines drug formulation and impacts formulation requirements based on intended effect.

17
New cards

Principal Objective of Dosage Form Design

Ensure safe, effective, and consistent delivery of the active ingredient.

18
New cards

Five Qualities of an Ideal Dosage Form

Efficacy, safety, stability, convenience, and cost-effectiveness.

19
New cards

Excipients

Inactive substances used in formulations to support drug delivery.

20
New cards

Importance of Excipients

Improve stability, taste, solubility, and facilitate manufacturing.

21
New cards

Reference Book for Excipients

Handbook of Pharmaceutical Excipients, detailing compatibility and safety.

22
New cards

Properties of Excipients

Include physical, chemical, and functional properties.

23
New cards

Functions of Excipients

Include binders, disintegrants, and preservatives.

24
New cards

Safety Issues with Excipients

Can cause allergic reactions or toxicity at high doses.

25
New cards

Flavoring and Sweetening Agents

Improve patient compliance, especially in pediatric populations.

26
New cards

Dyes vs. Lakes

Dyes are water-soluble, while lakes are insoluble pigments used in solid dosage forms.

27
New cards

Levels of Flavors in Pharmaceuticals

Typically used at 0.1% to 1% of the formulation.

28
New cards

Levels of Colorants in Pharmaceuticals

Typically used at 0.001% to 0.01%, depending on dosage form.

29
New cards

Four Key Processes of Pharmacokinetics

Absorption, distribution, metabolism, and excretion (ADME).

30
New cards

Covalent Bonds

Strong, stable bonds formed by sharing electrons.

31
New cards

Ionic Bonds

Attraction between oppositely charged ions.

32
New cards

Hydrogen Bonds

Weak interactions involving hydrogen and electronegative atoms.

33
New cards

Intermolecular Forces

Forces between molecules affecting solubility and boiling points.

34
New cards

Intramolecular Forces

Forces within a molecule that determine structure.

35
New cards

Dipole

Separation of charges within a molecule due to electronegativity.

36
New cards

Types of Attractive Forces

Include van der Waals forces, dipole-dipole interactions, hydrogen bonds, and ionic bonds.

37
New cards

Repulsive Forces and Molecular Distance

Increase as molecules come closer due to electron cloud overlap.

38
New cards

States of Matter

Solid: fixed shape and volume; Liquid: fixed volume, variable shape; Gas: neither fixed shape nor volume.

39
New cards

Advantages of Solid Dosage Forms

Stable, convenient, controlled release, cost-effective.

40
New cards

Amorphous Solids vs. Crystalline Solids

Amorphous: disordered, higher solubility; Crystalline: ordered, more stable.

41
New cards

Melting Point

Temperature at which a solid becomes a liquid, indicating purity.

42
New cards

Polymorphism

Existence of a substance in multiple crystalline forms affecting properties.

43
New cards

Solvates

Crystals incorporating solvent molecules, impacting stability.

44
New cards

Cocrystals

Formed by combining API with co-former to enhance properties.

45
New cards

Particle Sizes for Various Dosage Forms

Tablets: 50–500 µm; Inhalation powders: 1–5 µm.

46
New cards

Advantages of Particle Size Reduction

Improves dissolution, uniform mixing, and stability.

47
New cards

Definitions of Solution and Solubility

Solution: homogeneous mixture; Solubility: max amount dissolved.

48
New cards

Importance of Water Solubility

Affects absorption, bioavailability, and therapeutic efficacy.

49
New cards

USP Solubility Expressions

Soluble: 1–10 parts; Sparingly Soluble: 30–100 parts.

50
New cards

Noyes-Whitney Dissolution Model

Describes the dissolution rate as influenced by various factors.

51
New cards

Factors Affecting Dissolution Rate

Particle size, temperature, and solvent viscosity.

52
New cards

Tablet Dissolution Process

Includes disintegration, dissolution, and absorption.

53
New cards

Lowry-Bronsted Definition of Acids/Bases

Acid donates a proton; Base accepts a proton.

54
New cards

Ionization of Strong vs. Weak Acids

Strong: fully ionized; Weak: partially ionized.

55
New cards

Degree of Ionization

Depends on pH relative to pKa for acids and bases.

56
New cards

Understanding Acidic and Basic Salts

Acidic: sodium acetate; Basic: ammonium chloride.

57
New cards

Advantages of Salt Formation

Improves solubility, stability, and absorption.

58
New cards

Buffers

Solutions resisting pH changes, composed of weak acid and conjugate base.

59
New cards

Henderson-Hasselbalch Equation

Used for calculating pH based on acid/base concentrations.

60
New cards

Drug Stability Types

Include physical, chemical, microbial, therapeutic, and toxicological.

61
New cards

Major Types of Chemical Instability

Hydrolysis, oxidation, photolysis, and racemization.

62
New cards

Hydrolysis Mechanism

Involves breaking chemical bonds using water.

63
New cards

Stratergies to Minimize Hydrolysis

Includes using desiccants and non-aqueous solvents.

64
New cards

Drug Oxidation Mechanism

Loss of electrons, initiated by various factors.

65
New cards

Photolysis

Degradation from light exposure.

66
New cards

Examples of Microbial Preservatives

Include parabens, benzalkonium chloride.

67
New cards

Shelf Life

Time during which a drug maintains potency; Expiry Date: end of this time.

68
New cards

Zero-Order Reaction

Constant rate of reaction independent of concentration.

69
New cards

First-Order Reaction

Rate depends on concentration of one reactant.

70
New cards

Calculations for Zero and First Order Kinetics

Different mathematical representations for each order of reactions.

71
New cards

Zero-Order Kinetics Applicability

Observed in suspensions due to continuous solid dissolution.

72
New cards

Identify Dosage Forms by Administration Route

Oral: Tablets; Parenteral: IV solutions; Topical: Creams.

73
New cards

Blood Plasma Concentration-Time Curve

Visual representation of drug absorption, distribution, metabolism, and excretion.

74
New cards

Biopharmaceutics

Studies the effects of formulations and physiology on ADME.

75
New cards

Absorption and First-Pass Effect

Drugs in GI tract pass through the liver, affecting bioavailability.

76
New cards

Concentration Gradients in Drug Diffusion

Higher concentrations lead to faster diffusion rates.

77
New cards

One-Compartment Pharmacokinetic Model

Assumes the body acts as a single compartment.

78
New cards

Clearance in Pharmacokinetics

Volume of plasma cleared of drug per unit time.

79
New cards

Predicting Half-Life Changes

Increased clearance reduces half-life; increased Vd prolongs half-life.

80
New cards

Q10 Method for Shelf Life Determination

Predicts degradation rate changes with temperature.

81
New cards

Stability Testing Protocols

Assess physical and chemical stability over time.

82
New cards

Types of Containers by Material

Include glass, plastic, and metal with respective applications.

83
New cards

Single Dose Containers vs. Multiple-Dose Containers

Single-use without preservatives; multiple-use with preservatives.

84
New cards

Well-Closed vs. Tight-Closed Containers

Protects against contamination and air/moisture entry.

85
New cards

Sorption and Leaching in Containers

Involves drug absorbing into and container components migrating into drug.

86
New cards

Biotechnology Impact on Pharmaceuticals

Enables production of biologics and personalized therapies.

87
New cards

Small Molecule vs. Biotech Drugs

Small molecules are chemically synthesized; biotech drugs are complex proteins.

88
New cards

Applications of Polymers

Controlled-release delivery systems, stabilizers, bioadhesive systems.

89
New cards

Pharmaceutical Nanotechnology

Focuses on nanoparticle design for targeted drug delivery.

90
New cards

Advantages of Nano-Based Delivery Systems

Enhanced solubility and reduced side effects.

91
New cards

Phospholipids

Amphiphilic molecules forming liposome structures for drug delivery.

92
New cards

Types of Liposomes

Include conventional, stealth, and immunoliposomes for varied applications.

93
New cards

Immunoliposomes

Targeted drug delivery vehicles functionalized with antibodies.

94
New cards

Polymeric Micelles vs. Lipid Micelles

Polymeric are more stable; lipid are formed from phospholipids.

95
New cards

Construction of Dendrimers

Highly branched macromolecules for targeted drug delivery applications.

96
New cards

Applications of Dendrimers

Targeted delivery, gene therapy, drug solubilization.

97
New cards

Types of Solid Nanoparticles

Includes nanospheres and nanocapsules for drug delivery.

98
New cards

Nanospheres vs. Nanocapsules

Nanospheres: matrix-type; Nanocapsules: core-shell structure.